Advertisement
MET vs MFC
Which Stock Would AI Choose? MetLife (MET) vs. Manulife Financial (MFC) Stock Comparison
Key Takeaways
- MET is a New York-based global insurer with a diversified portfolio spanning Group Benefits, Retirement & Income Solutions, Asia, Latin America, and EMEA (Europe, the Middle East, and Africa), while MFC is a Toronto-based global insurer and asset manager with an outsized Asia franchise and a substantial wealth-management business.
- Both companies posted double-digit earnings growth in their most recent quarter, with MET delivering stronger relative share-price momentum and a higher adjusted return on equity (ROE), a measure of profitability.
- MFC's growth is concentrated in Asia and wealth management, whereas MET's earnings are more diversified across U.S. and international insurance segments.
- Tickeron AI Verdict: MET — the AI currently favors MetLife on the strength of more consistent trend alignment, earnings beats, and broader earnings diversification.
- For more context, explore MET Major News and MET Today's Price Move, as well as MFC Major News and MFC Today's Price Move.
- To see how AI evaluates thousands of tickers in real time, explore the Trending AI Robots.
Introduction
Investors comparing large-cap life insurers often weigh diversification, growth drivers, and capital discipline. MET (MetLife, Inc.) and MFC (Manulife Financial Corporation) both fit this profile, yet they differ meaningfully in geographic mix and business composition. This stock comparison is most relevant for value and dividend-oriented investors, as well as traders tracking relative performance within the insurance and financial-services sector. Understanding how each company's recent momentum, earnings quality, and market positioning differ can help clarify which name currently offers the more consistent risk-reward profile in a shifting rate and macroeconomic environment.
MET Overview and Recent Performance
MetLife is one of the world's largest life insurers, operating through Group Benefits, Retirement & Income Solutions (RIS), Asia, Latin America, EMEA, and MetLife Investment Management. In its most recent quarter, MET reported adjusted operating earnings per share (EPS) up roughly 23% year over year, beating consensus estimates, while adjusted revenue improved about 4.5%. Strength was broad-based, led by Group Benefits, Asia, and EMEA, supported by higher net investment income and favorable underwriting.
Recent market activity has reflected this operating momentum. Shares have advanced notably over recent months, with the company's year-to-date return outpacing its industry and sector. Sentiment has been reinforced by a substantial new share-repurchase authorization, a resilient adjusted ROE, and a steady stream of analyst "Buy" ratings. The main watch items are expense discipline and investment-spread pressures, but the overall trend has remained constructive.
MFC Overview and Recent Performance
Manulife Financial is a leading Canada-headquartered insurer and asset manager, with core operations in Asia, Canada, and the United States, plus its Global Wealth and Asset Management (Global WAM) business. In its latest reported quarter, MFC posted core EPS growth of about 11% year over year, while net income attributable to shareholders rose sharply. Asia was the standout, with core earnings up roughly 22%, alongside double-digit growth in new business value (NBV) and annualized premium equivalent (APE) sales, a standard measure of new insurance sales.
Recent stock behavior has been steady but more moderate than MET's. Growth has been partly offset by net outflows in Global WAM, unfavorable group-insurance experience in Canada, and lower U.S. investment spreads. On the positive side, MFC maintains a strong capital position — its LICAT ratio (Life Insurance Capital Adequacy Test, a regulatory solvency measure) stood at 136% — and continues returning capital through dividends and buybacks.
Trending AI Robots
Tickeron maintains a curated Trending AI Robots section featuring the most suitable automated trading strategies for current market conditions. While Tickeron's platform includes hundreds of AI trading bots that collectively trade thousands of different tickers, only a select group earns a place in this shortlist. Each robot is built around its own trading style, strategy, timeframe, performance record, and set of tickers, so no two bots are identical. The trending selection is designed to help traders quickly identify strategies that align with prevailing market dynamics. For a current view of which automated approaches are performing best across MET, MFC, and the broader market, explore the Trending AI Robots page.
Head-to-Head Comparison
The core contrast between these two insurers is geographic and business-model mix. MET is a U.S.-centric franchise with meaningful global diversification, giving it broad earnings stability across group benefits, retirement, and international markets. MFC is more concentrated in Asia growth and wealth management, which offers higher-growth potential but also introduces exposure to net-fund-flow volatility and Canadian group-insurance claims experience.
On recent momentum, MET has shown stronger relative performance, supported by consistent earnings beats and a sizable buyback program. MFC's catalysts are more mixed, with impressive Asia execution offset by wealth-management outflows and U.S. spread compression. From a risk standpoint, both names are sensitive to interest rates and credit conditions; MET's broader diversification provides somewhat smoother earnings, while MFC's Asia franchise and asset-management scale offer distinct long-term growth levers. Market sentiment has leaned more decisively positive toward MET in recent weeks, reflected in a higher consensus rating and upward price-target revisions.
Tickeron AI Verdict
Based on observable factors — trend consistency, earnings momentum, earnings diversification, and relative positioning — Tickeron's AI would currently favor MET over MFC. MetLife's combination of broad-based segment strength, consecutive earnings beats, disciplined capital returns, and firmer price momentum suggests a more consistent alignment of trend and fundamental signals. MFC's Asia-led growth remains compelling, but softer wealth-management flows and more mixed segment results introduce greater variability into its near-term profile. This assessment is probabilistic rather than definitive and reflects current data rather than a forecast of future prices.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MET is a StrongBuy and MFC is a StrongBuy.
MET in +1.25% Uptrend, growing for three consecutive days on November 11, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in 229 of 346 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 34 of 55 cases where MET's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on MET as a result. In 45 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.
The Moving Average Convergence Divergence (MACD) for MET just turned positive on November 10, 2026. Looking at past instances where MET's MACD turned positive, the stock continued to rise in 32 of 53 cases over the following month. The odds of a continued upward trend are 60%.
MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 153 of 283 cases where MET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
Bearish Trend Analysis
The 10-day RSI Indicator for MET moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 20 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 43%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 24 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.276) is slightly higher than the industry average of (1.337). P/E Ratio (18.683) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.024) settles around the average of (0.047) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
MFC in upward trend: price may jump up because it broke its lower Bollinger Band on November 06, 2026
MFC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 23 of 32 cases where MFC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 72%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 31 of 47 cases where MFC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 66%.
MFC moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MFC crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 47%.
Following a +0.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where MFC advanced for three days, in 225 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
The Aroon Indicator entered an Uptrend today. In 191 of 355 cases where MFC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
Bearish Trend Analysis
The 10-day RSI Indicator for MFC moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator moved out of overbought territory. In 20 of the 45 cases, the stock moved lower in the following days. This puts the odds of a move lower at 44%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MFC as a result. In 40 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 53%.
The Moving Average Convergence Divergence Histogram (MACD) for MFC turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 20 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 43%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MFC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. MFC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.537) is normal, around the industry mean (1.337). P/E Ratio (11.686) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.876) is also within normal values, averaging (0.463). Dividend Yield (0.033) settles around the average of (0.047) among similar stocks. P/S Ratio (1.780) is also within normal values, averaging (1.303).
The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
MET | MFC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 29 | 42 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 55 Fair valued | 53 Fair valued | |
PROFIT vs RISK RATING 1..100 | 20 | 4 | |
SMR RATING 1..100 | 99 | 100 | |
PRICE GROWTH RATING 1..100 | 24 | 43 | |
P/E GROWTH RATING 1..100 | 15 | 76 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MFC's Valuation (53) in the Life Or Health Insurance industry is in the same range as MET (55). This means that MFC’s stock grew similarly to MET’s over the last 12 months.
MFC's Profit vs Risk Rating (4) in the Life Or Health Insurance industry is in the same range as MET (20). This means that MFC’s stock grew similarly to MET’s over the last 12 months.
MET's SMR Rating (99) in the Life Or Health Insurance industry is in the same range as MFC (100). This means that MET’s stock grew similarly to MFC’s over the last 12 months.
MET's Price Growth Rating (24) in the Life Or Health Insurance industry is in the same range as MFC (43). This means that MET’s stock grew similarly to MFC’s over the last 12 months.
MET's P/E Growth Rating (15) in the Life Or Health Insurance industry is somewhat better than the same rating for MFC (76). This means that MET’s stock grew somewhat faster than MFC’s over the last 12 months.
| MET | MFC | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 43% | 1 day ago 44% |
| Stochastic ODDS (%) | 1 day ago 62% | 1 day ago 66% |
| Momentum ODDS (%) | 1 day ago 54% | 1 day ago 53% |
| MACD ODDS (%) | 1 day ago 60% | 1 day ago 43% |
| TrendWeek ODDS (%) | 1 day ago 61% | 1 day ago 47% |
| TrendMonth ODDS (%) | 1 day ago 54% | 1 day ago 57% |
| Advances ODDS (%) | 1 day ago 66% | 1 day ago 64% |
| Declines ODDS (%) | 6 days ago 51% | 6 days ago 50% |
| BollingerBands ODDS (%) | 1 day ago 47% | 1 day ago 72% |
| Aroon ODDS (%) | 1 day ago 54% | 1 day ago 54% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MET’s FA Score shows that 3 FA rating(s) are green while MFC’s FA Score has 1 green FA rating(s).
- MET’s FA Score: 3 green, 2 red.
- MFC’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MET’s TA Score shows that 7 TA indicator(s) are bullish while MFC’s TA Score has 6 bullish TA indicator(s).
- MET’s TA Score: 7 bullish, 3 bearish.
- MFC’s TA Score: 6 bullish, 4 bearish.
Price Growth
MET (@Life/Health Insurance) experienced а +0.05% price change this week, while MFC (@Life/Health Insurance) price change was -3.28% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.56%. For the same industry, the average monthly price growth was +3.48%, and the average quarterly price growth was -0.70%.
Reported Earning Dates
MET is expected to report earnings on Feb 03, 2027.
MFC is expected to report earnings on Feb 17, 2027.
Industries' Descriptions
@Life/Health Insurance (+0.56% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
Advertisement
MET and
Correlation & Price change
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.
MFC and
Correlation & Price change
A.I.dvisor indicates that over the last year, MFC has been loosely correlated with MET. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MFC jumps, then MET could also see price increases.